Literature DB >> 3723114

Antibody response to the rubella virus structural proteins in infants with the congenital rubella syndrome.

A de Mazancourt, M N Waxham, J C Nicolas, J S Wolinsky.   

Abstract

Forty-five serum samples from 31 newborns and infants with the congenital rubella syndrome (CRS) were tested by immunoprecipitation to determine their antibody spectra to each of the structural proteins of rubella virus. Most sera (37/45) contained little or no E2 protein-specific antibody, but some (6/45) precipitated a greater amount of the E2 glycoprotein than the E1 glycoprotein. The relative E1/E2 ratio was found to decrease with time when serial serum samples from the same patient were tested. No correlation between the IgG class hemagglutination inhibition antibody titers and the E1/E2 ratio could be demonstrated. However, in some serum specimens relatively high neutralizing antibody titers were correlated with immunoprecipitation of the E2 glycopolypeptide. None of the CRS sera reacted well with the C protein. The immunoprecipitation patterns found in CRS sera were qualitatively different from those observed in a series of 25 sera from young adults with conventional serologic evidence of rubella immunity following natural infection. All of the natural immune sera recognized each of the three structural polypeptides of rubella virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723114     DOI: 10.1002/jmv.1890190203

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays.

Authors:  T Zhang; C A Mauracher; L A Mitchell; A J Tingle
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies.

Authors:  W G Starkey; J Newcombe; K M Corbett; K M Liu; P G Sanders; J M Best
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

4.  Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.

Authors:  J S Wolinsky; M McCarthy; O Allen-Cannady; W T Moore; R Jin; S N Cao; A Lovett; D Simmons
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.

Authors:  L A Mitchell; T Zhang; M Ho; D Décarie; A J Tingle; M Zrein; M Lacroix
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides.

Authors:  D Ou; P Chong; B Tripet; S Gillam
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  Reactivity of a recombinant rubella E1 antigen expressed in E. coli.

Authors:  P Londesborough; G Terry; L Ho-Terry
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  A bio-engineered rubella E1 antigen.

Authors:  G M Terry; L Ho-Terry; P Londesborough; K R Rees
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 9.  Molecular biology of rubella virus.

Authors:  T K Frey
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.